Results 11 to 20 of about 38,436 (213)

Leptomeningeal Seeding of Pituitary Adenoma in a Young Lady With Neglected Gigantism: An Extremely Rare Case Report. [PDF]

Clin Case Rep
ABSTRACT Pituitary neuroendocrine tumors can sometimes present with leptomeningeal seeding at their initial diagnosis, emphasizing the need for thorough evaluation in cases of leptomeningeal involvement. Additionally, it is crucial for general physicians to inquire about a patient's menstrual status, particularly in low socioeconomic conditions, as ...
Bagherzadeh S, Shafizadeh M, Tavangar SM, Khoshnevisan A.   +3 more
europepmc   +2 more sources

Knowledge and attitudes of primary care physicians regarding acromegaly: a survey study with multinational participation [PDF]

BMC Primary Care
Background Acromegaly is a disease with high morbidity and mortality rates. The role of primary care physicians is very important in the early diagnosis of acromegaly.
Aysen Kutan Fenercioglu, Ebru Unur Demircan, Gunay Can, Cem Sulu, Nurver Turfaner Sipahioglu, Hande Mefkure Ozkaya, Pinar Kadioglu   +6 more
doaj   +2 more sources

Integration of an enhanced recovery after surgery program for patients undergoing pituitary surgery

World Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 8, Issue 4, Page 330-338, December 2022., 2022
Abstract Evidence‐based enhanced recovery after surgery (ERAS) programs aim to improve patient outcomes and shorten hospital stays. The objective of this study is to describe the development, implementation, and evolution of an ERAS protocol to optimize the perioperative management for patients undergoing endoscopic skull base surgery for pituitary ...
Stephanie Flukes, Ilya Laufer, Jennifer Cracchiolo, Eliza Geer, Andrew L. Lin, Jess Brallier, Van Tsui, Anoushka Afonso, Viviane Tabar, Marc A. Cohen   +9 more
wiley   +1 more source

Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan

Frontiers in Endocrinology, 2022
Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabolic,
Marek Bolanowski, Zaina Adnan, Mirjana Doknic, Mykola Guk, Václav Hána, Irena Ilovayskaya, Darko Kastelan, Tomaz Kocjan, Tomaz Kocjan, Martin Kužma, Akmaral Nurbekova, Catalina Poiana, Nikolette Szücs, Silvia Vandeva, Roy Gomez, Sorin Paidac, Damien Simoneau, Ilan Shimon   +17 more
doaj   +1 more source

High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.

Journal of Clinical Endocrinology and Metabolism, 2022
INTRODUCTION Osteopathy and morphometric vertebral fractures (VFs) are emerging complications in acromegaly. However, the prediction of VFs in this clinical setting is still a matter of uncertainty, and debated if they are an early event in the natural ...
S. Frara, M. M. Uygur, L. di Filippo, M. Doga, M. Losa, Simona Santoro, P. Mortini, A. Giustina   +7 more
semanticscholar   +1 more source

Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States

Pituitary, 2022
Purpose Patients receiving treatment for acromegaly often experience significant associated comorbidities for which they are prescribed additional medications.
M. Fleseriu, A. Barkan, Maria del Pilar Schneider, Yannis Darhi, A. de Pierrefeu, A. Ribeiro-Oliveira, S. Petersenn, S. Neggers, S. Melmed   +8 more
semanticscholar   +1 more source

Sex difference in patients with controlled acromegaly—A multicentre survey

Clinical Endocrinology, Volume 98, Issue 1, Page 74-81, January 2023., 2023
Abstract Objective Active acromegaly is subject to sex differences in growth hormone (GH) and Insulin like growth factor 1 (IGF‐I) patterns as well as clinical features but whether this also pertains to controlled disease is unclear. Design In a cross‐sectional, multi‐centre study, 84 patients with acromegaly (F = 43, M = 41), who were considered ...
Jakob Dal, Christian Rosendal, Jesper Karmisholt, Ulla Feldt‐Rasmussen, Marianne S. Andersen, Marianne Klose, Claus feltoft, Ansgar Heck, Eigil H. Nielsen, Jens O. L. Jørgensen   +9 more
wiley   +1 more source

Preoperative medical treatments and surgical approaches for acromegaly: A systematic review

Clinical Endocrinology, Volume 98, Issue 1, Page 14-31, January 2023., 2023
Abstract Objective Acromegaly is a condition characterized by an overproduction of growth hormone which infers high morbidity and mortality if left untreated. The objective of this review is to analyse and appraise the current evidence for the generalized use of preoperative medications and the various surgical approaches as described in the literature.
Christos Papaioannou, Maralyn Druce
wiley   +1 more source

Global epidemiology of acromegaly: a systematic review and meta-analysis.

European Journal of Endocrinology, 2021
OBJECTIVE To date, no systematic reviews and meta-analysis on the global epidemiology of acromegaly are available in literature. The aims of this study are to provide a systematic review and a meta-analysis of the global epidemiology of acromegaly and to
S. Crisafulli, N. Luxi, J. Sultana, A. Fontana, F. Spagnolo, G. Giuffrida, F. Ferraù, D. Gianfrilli, A. Cozzolino, M. D. De Martino, F. Gatto, F. Barone-Adesi, S. Cannavò, G. Trifirò   +13 more
semanticscholar   +1 more source

Presence of cerebral microbleeds is associated with cognitive decline in acromegaly

Frontiers in Oncology, 2022
BackgroundCognitive decline in acromegaly has gained increasing attention. Cerebral microbleeds (CMBs) as radiographic markers for microvascular injury have been linked to various types of cognitive decline. However, the association between CMB formation
Zhengxing Xie, Zhengxing Xie, Zhengxing Xie, Yan Zhuang, Yan Zhuang, Zongqiang Zhang, Jieping Liu, Jieping Liu   +7 more
doaj   +1 more source